CNIO Bioinformatics Unit

Welcome to the CNIO Bioinformatics Unit website!

Our group has a double component of bioinformatics support to Spanish National Cancer Research Centre (CNIO) and external investigators and research in bioinformatics. Lab research activity is focused on the development of novel computational techniques for the integration of cancer genomic data with clinical and pathological features. Our final goal is to translate this knowledge from cancer genome-scale studies to effective cancer patient’s treatment.

PanDrugs article has been published in Genome Medicine!

We are proud to announce that PanDrugs paper has been published in Genome Medicine today. The article can be accessed here. We want to thank all BU staff, SING group and all our collaborators for making it possible!     …

Open position for a bioinformatician to work in our cancer pharmacogenomic projects. Omics data analysis focused on renal cell carcinoma biomarkers. Great work environment and excellent cancer research at @CNIOStopCancer
More info
https://cnio.es/empleo/advanced-degree-for-the-hereditary-endocrine-cancer-group-tsceh10/
Please, spread the word.

Are you interested in working in an international research centre, @CNIOStopCancer and in biobanking? @CNIOBiobank is looking for a Data Manager for #RENACER (National Brain Metastatis Network). Have a look at the add and apply 👉https://www.cnio.es/en/empleo/titulado-superior-para-el-biobanco-tsbioban5-2/

New #JobOffer | Bioinformatician to join the Bioinformatics Unit @BU_CNIO at the @CNIOStopCancer on the #collection, #analysis, and #interpretation of biological/clinical data. #NGS #cancer

➡️ https://inb-elixir.es/jobs/bioinformatician-bioinformatics-unit-0

Load More...

OPEN POSITIONS

We are always open to motivated and talented postdoctoral candidates, graduate students and summer rotation students in areas of computational biology, and medicine or molecular biology applicants with an interest in computational biology.

For questions regarding available training opportunities, please contact us.